Usine-AFYREN-NEOXY-fermenteurs crédits

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

AFYREN announces the industrial commissioning of its AFYREN NEOXY plant and publishes its 2021 Full-Year Results

  •  Finalization of the construction of the AFYREN NEOXY plant at cost and on time despite the health crisis context
  • Industrial commissioning of the plant with the launch of the test phase
  • Strong cash position of €67 million at the end of 2021 following the success of the IPO
  • Execution of the strategy in line with the plan presented at the IPO and confirmation of the financial outlook and objectives

Nicolas SORDET, AFYREN’s CEO, stated: “2021 was a transforming year for AFYREN, culminating in the IPO in September. The year 2022 also promises to be full of challenges and we are pleased to have met the first one with the launch of the industrial commissioning of our AFYREN NEOXY plant on the Carling Saint-Avold site, in accordance with the announced schedule and at cost. We now have the financial resources and a first industrial tool to accelerate the achievement of our Purpose, “We enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”.”

 

Industrial commissioning of AFYREN NEOXY plant

In the second half of 2020, AFYREN launched the construction of AFYREN NEOXY, its first large-scale plant, located in Carling-Saint Avold, in the Grand Est region. AFYREN NEOXY is the first industrial-scale plant for the production of biobased carboxylic acids from sugar beet co-products.
Today, the construction phase for this plant is nearing completion: all the equipment has been delivered and the acceptance and start-up process is underway in accordance with the planned schedule. These tests will be spread out over several weeks for a gradual commissioning of the different equipment, a test phase that will prepare the launch of production.

Jean SAINT-DONAT, President of AFYREN NEOXY, adds: “The industrial commissioning of the AFYREN NEOXY plant is a key step in the history of AFYREN. We are ready to start and deliver the first batches of biobased acids developed with AFYREN technology this year. We are facing this transition to industrial scale with serenity alongside the fifty or so new employees already recruited and trained, and we are confirming our deep commitment to the environment by promoting short supply and sales channels thanks to our strategic geolocation in the heart of Europe.”

 

2021 key financial elements

Sales in 2021 amount to €3.04 million, against €3.99 million in 2020. The sales are essentially composed of income from the various contracts concluded with AFYREN NEOXY (patent and know-how licenses, services related to the obtaining of the BBI grant1 by AFYREN NEOXY, commercial and administrative assistance services).
As expected, the Company recorded a net loss in 2021, amounting to €3.61 million (compared to €2.13 million in 2020), as a consequence of the acceleration of investments prior to the operation of the industrial units.

 

Purpose and extra-financial rating significantly improved

Following several months of reflection and consultation with its internal and external stakeholders, AFYREN and its board of directors define and formalize its Purpose in early 2022: “We enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment.”

 

Full Press release:

Download

Latest News

AFYREN signs new contract to provide biobased organic acid to U.S. manufacturer of industrial lubricants

The multi-year deal will help the customer cut Scope 3 emissions and make progress on its climate neutrality goals.  AFYREN offers a biobased alternative to the traditionally used petroleum-based molecules, acting on the value chain of the companies and offering them a highly improved carbon balance. AFYREN has now pre-sold 75% of its AFYREN NEOXY factory’s targeted production volume of organic acids. Clermont-Ferrand/Lyon, 17th of November 2022, 8:00 am CEST – AFYREN, a greentech company that offers manufacturers bio-based, low-carbon products made using technology based on natural micro-organisms, today announced that it had signed a new multi-year contract to provide […]

AFYREN NEOXY signs deal with Excellentia for distribution in key North American flavors and fragrances market

Excellentia will distribute the FLAVYREN™ line to the major North American players in the flavors and fragrances market.  The deal covers the full suite of FLAVYREN™ natural organic acids produced by AFYREN NEOXY . North America is the No. 2 global market for flavors and fragrances, with growth estimated at more than 6%.   Clermont-Ferrand/Lyon, 9th of November 2022, 8:00 am CEST – AFYREN, a greentech company that offers manufacturers bio-based, low-carbon products made using technology based on natural micro-organisms, today announced that it has signed a North American distribution agreement with Excellentia, a leading player in the supply of natural […]

AFYREN inaugurates its first factory, AFYREN NEOXY, a first-of-its-kind biorefinery

The plant, in Carling Saint-Avold in France’s Moselle region, uses short supply chains to produce seven 100% biobased acids that offer customers in sectors such as food, flavors and fragrances or chemicals as an alternative to the petro-based acids usually used A unique, low-carbon, zero-waste biorefinery strategically located in the heart of Europe for its international customers and suppliers Production will ramp up to 16,000 metric tons of biobased carboxylic acids in 2024, saving 30,000 tons of CO2 emissions per year A unique industrial accomplishment resulting from the association between AFYREN and Bpifrance, through its Sociétés de Projets Industriels (SPI) […]

AFYREN diversifies sales with two strategic contracts to supply players in the cosmetics and nutraceuticals markets

At the end of a summer during which climate change was top-of-mind worldwide, major economic players are stepping up efforts to reduce their impact on the environment. AFYREN’s latest contracts underscore the fact that its low-carbon business model is attracting increasing interest from a variety of companies that are looking for more sustainable ingredients. With these deals, AFYREN has secured sales of 70% of the projected output of organic acids from the AFYREN NEOXY plant to a variety of customers in diverse markets. Clermont-Ferrand/Lyon, 30th of August 2022, 8:00 am CEST – AFYREN, a greentech company that offers manufacturers bio-based, […]

From natural fermentation to an industrial and innovative biomimetic process

Today, more than half of all companies say they are committed to sustainable development, but it is becoming increasingly clear that reconciling environmental and economic performance involves many difficult choices. Only 21% of companies have a clear roadmap for implementing their sustainability strategies. At AFYREN, we believe that sharing knowledge and experience can contribute to a more sustainable future. In our blog posts, we seek to share the expertise we have developed on our own journey toward a sustainable, circular business model. In 2021, the world used up the equivalent of 1.7 planets’ worth of resources to satisfy production and […]